Empirical Finance, LLC Blueprint Medicines Corp Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$45.23 - $70.15 $258,172 - $400,416
-5,708 Closed
0 $0
Q4 2021

Feb 04, 2022
SELL
$94.25 - $115.99 $399,902 - $492,145
-4,243 Reduced 42.64%
5,708 $611,000
Q2 2021

Aug 10, 2021
BUY
$82.78 - $101.0 $823,743 - $1.01 Million
9,951 New
9,951 $875,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email